Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-75
SponsorShanghai Jiao Tong University School of Medicine

About this trial

The purpose of this study is to To confirm the predictive value of CCND1 for TPF induction in cN2 patients with OSCC

Eligibility criteria

Qualifiers

Age: 18 to 75 years old.

Sex: both males and females.

Karnofsky performance status (KPS) >60.

Histological biopsy confirming squamous cell carcinoma of the oral cavity (tongue, gingiva, buccal mucosa, floor of mouth, palate, and retromolar region).

Disqualifiers

Evidence of distant metastatic disease and other cancers.

Surgical procedure of the primary tumors or lymph nodes (except diagnostic biopsy).

Previous radiotherapy or chemotherapy.

Other previous malignancies within 5 years.

Trial design

Treatments tested in this trial

  • TPF group
  • surgery group
  • Post-operative radiotherapy

Treatment groups

48 Participants
are divided into 2 treatment groups